Varian Stands Firm Against Rival Bid For SirTex; What Next If It All Falls Down?

Varian Medical Systems' proposed $1.3bn deal to acquire SirTex Medical is officially in jeopardy after China's CDH Investments formalized its rival bid to snatch away the Australian interventional oncology firm. Should the deal fall through, what would Varian's next steps be?

More from Oncology

More from Device Area